TL;DR
Get wellness gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Intake Breathing received a $62 million investment from Camino Partners, the firm founded by Kind Snacks creator Daniel Lubetzky. The family-run company says it plans to use the funding to expand beyond direct-to-consumer sales into physical retail and specialty channels, and to hire for growth. The investment amount is confirmed in the source report; the company’s future growth and broader consumer adoption remain prospective.
Intake Breathing has received a $62 million investment from Camino Partners, the firm founded by Kind Snacks creator Daniel Lubetzky, as the family-run company prepares to expand its magnetic nasal-device business into physical retail and specialty channels. Intake says the money will also support key hires; terms of the investment were not disclosed in the source report.
Founded by inventor and medical-device engineer Jim Castillo, Intake is led by his son-in-law, co-founder and CEO Alex Hauck. The company sells a nasal dilator that pairs a reusable magnetic band with adhesive tabs. Intake says the device is designed to mechanically open the nasal valve, the narrowest part of the nasal airway, to improve airflow. The report describes it as an alternative to conventional adhesive nasal strips.
Intake has built its business mainly through direct-to-consumer sales. The company plans to use the new capital to reach shoppers through physical retail and specialty channels, while adding staff to support its next stage of growth. The report does not identify specific retailers, hiring targets, launch dates or a breakdown of how the $62 million will be allocated.
The report calls this Intake’s first significant outside capital infusion and frames it as a move from a family-run operation toward a broader consumer brand. The company has gained visibility among professional athletes, including Los Angeles Dodgers pitcher Justin Wrobleski and Belgian soccer player Amadou Onana. Athlete use may raise the product’s profile, but it does not establish that the device improves athletic performance.
A Retail Push for Nasal Devices
The investment gives Intake substantial funding and a partner with experience in consumer brands as it tries to move beyond selling primarily online. Retail access could put the device in front of shoppers who may not seek out a specialized nasal-breathing product directly. Whether the expansion succeeds will depend in part on distribution, repeat purchases, consumer awareness and the company’s ability to explain how its product differs from established nasal strips.
Camino is positioning the opportunity as part of wider consumer interest in sleep, recovery and performance optimization. That is the investor’s view of the market, not proof that demand will reach the scale it expects. The funding is significant for Intake’s growth plans, while the report provides no sales figures, valuation or forecasts with which to measure the company’s current market position.
The product also sits at the intersection of consumer wellness and a claim about airflow. Intake describes how its device is intended to work, but the supplied report does not present clinical evidence, regulatory details or independent testing results. Readers should distinguish the company’s intended function from verified health or performance outcomes.
Products Worth Considering
Fitbit Versa Smart Watch – Black Aluminum, One Size (S & L Bands Included)
Fitbit Versa 2 Health and Fitness Smartwatch with Bonus Bands
BowFlex SelectTech 840 Adjustable Kettlebell
As an affiliate, we earn on qualifying purchases.
From Garage Invention to Funding
Hauck said the business began as a solution to a problem his father-in-law encountered in his garage. The company was founded by Castillo and later led by Hauck, according to the report. The $62 million investment marks a new financing stage for a business that had primarily relied on direct-to-consumer sales.
Camino’s portfolio includes Barry’s, a boutique fitness brand, and Athletic Brewing, a nonalcoholic beer maker, among other health-oriented businesses. Lubetzky drew a comparison between the opportunity he sees for Intake and the consumer shift toward whole-food snacks that he associated with Kind’s development. That comparison explains Camino’s investment thesis; it does not establish that nasal devices will follow the same commercial path.
The source report presents breathing optimization as an area drawing attention in fitness and wellness, and cites professional athletes who have used Intake. It does not provide market-size data or evidence about how common such products are among consumers. The immediate confirmed change is the financing and the company’s stated plan to expand distribution.
““We’re not just gaining capital, we’re gaining a partner who knows exactly what it takes to help get us there.””
— Alex Hauck, Intake Breathing co-founder and CEO
Terms and Evidence Still Unreported
The source report does not disclose the investment’s structure, Camino’s ownership stake, Intake’s valuation, or whether other investors participated. It also does not give revenue, sales growth, profitability or current customer numbers, leaving the company’s financial position before the deal difficult to assess.
Intake has described the device’s design and intended effect, but the report does not include independent clinical evidence or details about regulatory status. It does not establish that the product treats a medical condition or improves sleep, recovery or sports performance. The company’s plans for retail expansion are stated intentions; specific partners, locations and launch dates remain unreported.
Retail Expansion and Hiring Plans
Intake says it will direct funding toward physical retail and specialty-channel expansion and make key hires. The next measurable developments will be whether the company announces distribution partners, names new retail locations, or provides a timetable for those plans. No such details were included in the source report.
Further information about the deal’s terms and Intake’s financial performance could clarify the scale of Camino’s commitment and the company’s starting point for expansion. Until then, the confirmed development is the $62 million investment and the stated growth plan, rather than a demonstrated change in sales or consumer adoption.
Key Questions
Who invested in Intake Breathing?
Camino Partners, the investment firm founded by Kind Snacks creator Daniel Lubetzky, provided the reported $62 million investment.
What does Intake Breathing make?
Intake sells a nasal dilator that uses a reusable magnetic band and adhesive tabs. The company says the device is designed to open the nasal valve and improve airflow.
How does Intake plan to use the funding?
The company says it plans to expand into physical retail and specialty channels and make key hires. The report does not specify retailers, hiring numbers or an allocation of the funds.
Does the investment confirm the device improves sleep or athletic performance?
No. The report describes Intake’s intended product function and Camino’s market expectations, but it does not provide independent evidence establishing improved sleep, recovery or athletic performance.
Were the investment terms disclosed?
No. The source report gives the $62 million amount but does not state the deal structure, Camino’s ownership share or Intake’s valuation.
Source: athletechnews.com
